Side Effects of Seretide are Nausea, Vomiting, Respiratory tract infection, Fungal infections in the mouth, Headache, Hoarseness of voice, Sore throat, Cough, Musculoskeletal (bone, muscle or joint) pain, Increased heart rate.
Check the label for directions before use. Shake the inhaler. While you are breathing in from mouth, press down on the inhaler one time to release the medication and hold your breath for 10 seconds. Repeat until you have inhaled the number of puffs as suggested by the doctor.Afterwards, rinse your mouth thoroughly with water and spit it out.
Seretide 250 Evohaler is a combination of two medicines: Salmeterol and Fluticasone. Salmeterol is a long-acting bronchodilator which works by relaxing the muscles in the airways and widens the airways. Fluticasone is a steroid. It works by stopping the release of certain chemical messengers that cause inflammation (swelling) of the airways. Together, they make breathing easier.
Interaction with alcohol is unknown. Please consult your doctor.
WEIGH RISKS VS BENEFITS
Seretide 250 Evohaler may be unsafe to use during pregnancy. Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Seretide 250 Evohaler is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby.
What were the side-effects while using Seretide 250 Evohaler?
No Side Effect
How do you take Seretide Inhaler?
With or without food
How much was the improvement?
Please rate Seretide 250 Evohaler on price
What are you using Seretide Inhaler for?
Survey Participants: 11
“The following are the results of on-going survey on 1mg.com for Seretide 250 Evohaler. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
Information last updated by Dr. Varun Gupta, MD Pharmacology on 1st Dec 2017.